CoChat

Comparative Effectiveness of Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine+Liothyronine in Hypothyroidism

Open access
Shakir, Mohamed K M, Brooks, Daniel I, McAninch, Elizabeth A, Fonseca, Tatiana L, Mai, Vinh Q, Bianco, Antonio C, Hoang, Thanh D · 2021 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; 2 of the 6 sources its claims cite were checked for support.

Abstract

Introduction: Studies comparing levothyroxine (LT4) therapy with LT4 + liothyronine (LT3) or desiccated thyroid extract (DTE) did not detect consistent superiority of either treatment. Here, we investigated these therapies, focusing on the whole group of LT4-treated hypothyroid patients, while also exploring the most symptomatic patients. Methodology: Prospective, randomized, double-blind, crossover study of 75 hypothyroid patients randomly allocated to 1 of 3 treatment arms, LT4, LT4 + LT3, and DTE, for 22 weeks. The primary outcomes were posttreatment scores on the 36-point thyroid symptom questionnaire (TSQ-36), 12-point quality of life general health questionnaire (GHQ-12), the Wechsler memory scale-version IV (VMS-IV), and the Beck Depression Inventory (BDI). Secondary endpoints included treatment preference, biochemical and metabolic parameters, etiology of hypothyroidism, and Thr92Ala-DIO2 gene polymorphism. Analyses were performed with a linear mixed model using subject as a random factor and group as a fixed effect. Results: Serum TSH remained within reference range across all treatment arms. There were no differences for primary and secondary outcomes, except for a minor increase in heart rate caused by DTE. Treatment preference was not different and there were no interferences of the etiology of hypothyroidism or Thr92Ala-DIO2 gene polymorphism in the outcomes. Subgroup analyses of the 1/3 most symptomatic patients on LT4 revealed strong preference for treatment containing T3, which improved performance on TSQ-36, GHQ-12, BDI, and visual memory index (VMS-IV component). Conclusions: As a group, outcomes were similar among hypothyroid patients taking DTE vs LT4 + T3 vs LT4. However, those patients that were most symptomatic on LT4 preferred and responded positively to therapy with LT4 + LT3 or DTE.

Overview

CoChat Summary

## TL;DR

This prospective randomized double-blind crossover trial found no overall differences among levothyroxine (LT4), desiccated thyroid extract (DTE), and LT4+liothyronine in the full sample of 75 hypothyroid patients who completed the study. However, a subgroup analysis suggested that the most symptomatic patients on LT4 improved and preferred therapies containing T3 (DTE or LT4+LT3).

## Key findings

  • 75 of 90 enrolled patients completed the study; 15 withdrew before randomization because of relocations and time conflicts.
  • In the full cohort, there were no differences among treatments in the primary outcomes: TSQ-36, GHQ-12, BDI, or the 5 WMS-IV subdomains.
  • Serum thyroid measures shifted as expected with T3-containing therapies: fasting total T3 was 30% to 50% higher and serum T4 was about 30% lower on DTE or LT4+LT3; the T4/T3 ratio dropped 38% with LT4+LT3 and 56% with DTE.
  • In the subgroup analysis, the highest-symptom tercile on LT4 showed significant improvement after switching to LT4+LT3 (P = 0.0005) or DTE (P = 0.0008); the paper says these patients also preferred T3-containing therapy.

## Methods

  • Design: Prospective, randomized, double-blind, crossover trial registered at ClinicalTrials.gov NCT02317926.
  • Sample: 90 adults with primary hypothyroidism on stable LT4; 75 completed. Participants were mostly Caucasian (77.3%), female (77.3%), average age 50 years, and about 180 pounds.
  • Analysis: Mixed-effects models for treatment comparisons; Tukey-adjusted contrasts for between-treatment differences; Plackett-Luce model for treatment preference; subgroup tercile analyses with Kruskal-Wallis, Dunn tests, Holm adjustment, and one-sample exact Wilcoxon tests.

## Limitations

  • The paper explicitly states that a significant limitation was that the most notable findings came from a subanalysis not included in the primary outcomes, using a smaller subset and a between-subjects analysis.
  • The authors note the study was powered for within-subject differences in TSQ scores, not for the subgroup comparisons, so the subgroup results are less definitive.
  • Evident from the text: the subgroup findings may be affected by regression to the mean, which the authors discuss as a possible explanation.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1210/clinem/dgab478

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Flow diagram: enrollment, allocation, and completion of the study. Numbers of patients in each arm indicated in parentheses. DTE, desiccated thyroid extract; LT3- liothyronine; LT4, levothyroxine.
Figure 1. Flow diagram: enrollment, allocation, and completion of the study. Numbers of patients in each arm indicated in parentheses. DTE, desiccated thyroid extract; LT3- liothyronine; LT4, levothyroxine.CC BY · PubMed Central
Figure 2. Boxplots showing change scores from LT4 to the LT4/LT3 combination treatment, segmented by either low, medium, or high scores for those measures while on LT4. P value reports the results of a pairwise Dunn test for each set of comparisons. Multiple comparisons are adjusted using the Holm method.
Figure 2. Boxplots showing change scores from LT4 to the LT4/LT3 combination treatment, segmented by either low, medium, or high scores for those measures while on LT4. P value reports the results of a pairwise Dunn test for each set of comparisons. Multiple comparisons are adjusted using the Holm method.CC BY · PubMed Central
Figure 3. Boxplots showing change scores from LT4 to the DTE treatment, segmented by either low, medium, or high scores for those measures while on LT4. P value reports the results of a pairwise Dunn test for each set of comparisons. Multiple comparisons are adjusted using the Holm method.
Figure 3. Boxplots showing change scores from LT4 to the DTE treatment, segmented by either low, medium, or high scores for those measures while on LT4. P value reports the results of a pairwise Dunn test for each set of comparisons. Multiple comparisons are adjusted using the Holm method.CC BY · PubMed Central
Figure 4. A visualization of the pairwise correlation matrix between the various dependent measures, collected during treatment A. Positive correlations are displayed in blue with negative correlations displayed in red; the size of the circle and the intensity of the color denotes correlation strength. The diagonal is marked with a straight line of solid blue circles.
Figure 4. A visualization of the pairwise correlation matrix between the various dependent measures, collected during treatment A. Positive correlations are displayed in blue with negative correlations displayed in red; the size of the circle and the intensity of the color denotes correlation strength. The diagonal is marked with a straight line of solid blue circles.CC BY · PubMed Central
Figure 5. Boxplots showing change scores from LT4 to the DTE treatment, segmented by either low, medium, or high scores for those measures while on LT4. P value reports the results of a pairwise Dunn test for each set of comparisons. Multiple comparisons are adjusted using the Holm method.
Figure 5. Boxplots showing change scores from LT4 to the DTE treatment, segmented by either low, medium, or high scores for those measures while on LT4. P value reports the results of a pairwise Dunn test for each set of comparisons. Multiple comparisons are adjusted using the Holm method.CC BY · PubMed Central

Verification

Claims the paper makes

2 Valid · 0 Not valid · 1 Not checked · 35 Own results and interpretations

9 more claims

Create a free account to see all 38 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 19
  • Probably not a substantial claim. 10

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

7 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Research works printed but not linked: 3

  1. Roberts, Psychological problems in thyroid disease, Br Thyroid Foundation Newsl., 1996;18:3
  2. Wechsler, The Wechsler Memory Scalle-IV.
  3. McDowell, The General Health Questionnaire, Measuring Health. A guide to Rating Scales and Questionnaires.

Cited by

See all 92

Metadata

Authors
Shakir, M. K. M., Brooks, D. I., McAninch, E. A., Fonseca, T. L., Mai, V. Q., Bianco, A. C., & Hoang, T. D.
Affiliations
  • Uniformed Services University of the Health Sciences (US)
  • Walter Reed National Military Medical Center (US)
  • Rush University Medical Center (US)
  • University of Chicago (US)
Corresponding author
Hoang, Thanh D
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2021-06-29
Volume
106
Issue
11
Pages
e4400-e4413
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W3174863317
Cited by
92
References
32
Citations by year
2026: 7 · 2025: 25 · 2024: 17 · 2023: 21 · 2022: 16 · 2021: 6
FWCI
11.18
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Walter Reed National Military Medical Center Institutional Research Board
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
Keywords
hypothyroidism, levothyroxine, desiccated thyroid extract, liothyronine, thyroid hormone replacement, comparative effectiveness, thyroid symptoms, quality of life, depression, memory, heart rate, thyroid-stimulating hormone, treatment preferences
MeSH terms
Adult, Aged, Desiccation, Double-Blind Method, Female, Humans, Hypothyroidism, Male, Middle Aged, Placebos, Prospective Studies, Quality of Life, Surveys and Questionnaires, Thyroid Gland, Thyroxine, Tissue Extracts, Triiodothyronine, Treatment Outcome, Cross-Over Studies, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.